FDA Grants Fast Track Designation to CAR T-cell Therapy for Mesothelioma
By: Devin Golden
April 27, 2023
The U.S. Food and Drug Administration (FDA) issued a fast track designation to a CAR T-cell therapy for malignant mesothelioma. The FDA granted this designation to the CAR T-cell...
Read Post